Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04956120 · ClinicalTrials.gov registry record · NA
Effect of Citrate Dialysate on Vascular Calcification
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT04956120 is a NA study that has completed, run by Emory University. The registered enrollment target is 54 participants.
The verdict
NCT04956120, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether hemodialysis with citrate slows the progression of vascular calcification. Participants will be dialyzed with one of two standard dialysis solutions, one with and one without citrate, for 12 months and then switched to the other solution for 12 months. Vascular calcification will be measured on mammograms that will be performed at 6-month intervals and additional blood samples will be obtained at 6-month intervals.
Interventions
- DEVICE Citrate Dialysate
- DEVICE Standard Dialysate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2025-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04956120
The ClinicalTrials.gov registry entry for NCT04956120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Citrate Dialysate is the first listed.
NCT04956120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04956120 about?
NCT04956120 is a clinical study titled "Effect of Citrate Dialysate on Vascular Calcification". The goal of this study is to determine whether hemodialysis with citrate slows the progression of vascular calcification. Participants will be dialyzed with one of two standard dialysis solutions, one with and one without citrate, for 12 months and then switched to the other solution for 12 months. ...
What is the current status of trial NCT04956120?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2021-05-27. Estimated completion is 2025-03-18.
What interventions are being tested in trial NCT04956120?
The interventions under investigation include: Citrate Dialysate (DEVICE), Standard Dialysate (DEVICE).
Who is sponsoring clinical trial NCT04956120?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.